BeiGene Ltd - ADR (BGNE) Dividend History

BeiGene Ltd is a clinical-stage biopharmaceutical company engaged in the discovery & development of molecularly targeted & immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-283 and BGB-290 and one immuno-oncology agent.

Last update 07/22/2021


Dividend Yield Summary

  2016 2017 2018 2019 2020 2021
Dividends - - - - - -
Average Price 29.64 60.57 153.88 140.32 208.18 331.39
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2021 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note